Brompheniramine efficacy against cold symptoms shown in study, Whitehall tells FDA.
This article was originally published in The Tan Sheet
Executive Summary
BROMPHENIRAMINE STUDY "STRONGLY SUPPORTS" EFFICACY AGAINST COLDS, WHITEHALL told FDA in a May 7 submission on the antihistamine ingredient. The study, involving 225 subjects, was conducted by Jack Gwaltney, MD, University of Virginia, from November 1995 through August 1996. Results were submitted by Whitehall-Robins along with other data in response to the 1995 conclusion by a joint FDA advisory committee that there are insufficient data to establish the effectiveness of brompheniramine for the cold indication.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning